608350
Vericel Corporation — FEI 3002836339
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 21, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Cambridge, MA (United States)
Citations
| ID | CFR | Description |
| 1274 | 21 CFR 211.68(a) | Calibration/Inspection/Checking not done |
| 1451 | 21 CFR 211.113(b) | Procedures for sterile drug products |
| 3585 | 21 CFR 211.110(a) | Control procedures to monitor and validate performance |
| 4324 | 21 CFR 211.110(b) | In-process materials specifications testing |
| 4402 | 21 CFR 211.192 | Written record of investigation incomplete |
| 9089 | 21 CFR 600.14(c) | When to report |
| 9095 | 21 CFR 600.80(c)(1)(i) | Reporting Requirements - 15-day alert |